AR013019A1 - Polisacarido de sintesis, su utilizacion y composiciones farmaceuticas que lo contienen - Google Patents
Polisacarido de sintesis, su utilizacion y composiciones farmaceuticas que lo contienenInfo
- Publication number
- AR013019A1 AR013019A1 ARP990100172A ARP990100172A AR013019A1 AR 013019 A1 AR013019 A1 AR 013019A1 AR P990100172 A ARP990100172 A AR P990100172A AR P990100172 A ARP990100172 A AR P990100172A AR 013019 A1 AR013019 A1 AR 013019A1
- Authority
- AR
- Argentina
- Prior art keywords
- polysaccharide
- pharmaceutically acceptable
- pharmaceutical compositions
- preparation
- disorders associated
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
- C08B—POLYSACCHARIDES; DERIVATIVES THEREOF
- C08B37/00—Preparation of polysaccharides not provided for in groups C08B1/00 - C08B35/00; Derivatives thereof
- C08B37/006—Heteroglycans, i.e. polysaccharides having more than one sugar residue in the main chain in either alternating or less regular sequence; Gellans; Succinoglycans; Arabinogalactans; Tragacanth or gum tragacanth or traganth from Astragalus; Gum Karaya from Sterculia urens; Gum Ghatti from Anogeissus latifolia; Derivatives thereof
- C08B37/0063—Glycosaminoglycans or mucopolysaccharides, e.g. keratan sulfate; Derivatives thereof, e.g. fucoidan
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
- A61K31/726—Glycosaminoglycans, i.e. mucopolysaccharides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/04—Antihaemorrhagics; Procoagulants; Haemostatic agents; Antifibrinolytic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Organic Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Pharmacology & Pharmacy (AREA)
- Bioinformatics & Cheminformatics (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Molecular Biology (AREA)
- Biochemistry (AREA)
- Materials Engineering (AREA)
- Hematology (AREA)
- Polymers & Plastics (AREA)
- Diabetes (AREA)
- Cardiology (AREA)
- Heart & Thoracic Surgery (AREA)
- Vascular Medicine (AREA)
- Urology & Nephrology (AREA)
- Dermatology (AREA)
- Epidemiology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Polysaccharides And Polysaccharide Derivatives (AREA)
- Medicinal Preparation (AREA)
Abstract
Polisácarido de síntesis en forma de ácido y sus sales farmacéuticamente aceptables, cuya forma anionica responde a alguna de las formulas (I) a (V)siguientes. Composiciones farmacéuticas que contienen como principio activo el polisacárido enfor ma de sal con una base farmacéuticamente aceptable o enforma ácida, en asociacion o en mezcla con un excipiente inerte no toxico, farmacéuticamente aceptable; utilizacion del polisacárido para la preparacionde un medicamento util para laspatolo gías dependientes de una disfuncion de la coagulacion, y utilizacion del polisacárido para la preparacion de unmedicamento util para el tratamiento y la prevencion de los trastornos del sistema cardiovascular y cerebrovascular, lostrastornos tr omboembolicosasociados a la ateroesclerosis y a la diabetes, o a los trastornos tromboembolicos asociados a la retrombosis luego de una trombolisis, al infartoa la demencia de origen esquémico a las enfermedades arterialesperiféricas, a la hemodiálisis, a las fibrilaciones auriculares o también durante lautilizacion de protesis vasculares de by-pass aortocoronarios. Preferentemente las sales son aquellas cuyo cation se elige entre los cationes de losmetalesalcalinos. El polisacá rido definido anteriormente es utilizable como anticoagulante y antitrombotico.
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| FR9800515A FR2773804B1 (fr) | 1998-01-19 | 1998-01-19 | Polysaccharides de synthese, procede pour leur preparation et compositions pharmaceutiques le contenant |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| AR013019A1 true AR013019A1 (es) | 2000-11-22 |
Family
ID=9521914
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| ARP990100172A AR013019A1 (es) | 1998-01-19 | 1999-01-18 | Polisacarido de sintesis, su utilizacion y composiciones farmaceuticas que lo contienen |
Country Status (41)
| Country | Link |
|---|---|
| US (1) | US6528497B1 (es) |
| EP (1) | EP1049721B1 (es) |
| JP (1) | JP4402835B2 (es) |
| KR (1) | KR100513196B1 (es) |
| CN (1) | CN1165550C (es) |
| AR (1) | AR013019A1 (es) |
| AT (1) | ATE209219T1 (es) |
| AU (1) | AU741748B2 (es) |
| BR (1) | BRPI9907025B8 (es) |
| CA (1) | CA2317465C (es) |
| CO (1) | CO4970795A1 (es) |
| CZ (1) | CZ297815B6 (es) |
| DE (1) | DE69900718T2 (es) |
| DK (1) | DK1049721T3 (es) |
| DZ (1) | DZ2709A1 (es) |
| EE (1) | EE04157B1 (es) |
| EG (1) | EG23982A (es) |
| ES (1) | ES2168000T3 (es) |
| FR (1) | FR2773804B1 (es) |
| GT (1) | GT199900003A (es) |
| HK (1) | HK1030002A1 (es) |
| HR (1) | HRP20000480B1 (es) |
| HU (1) | HU228333B1 (es) |
| IL (1) | IL137241A0 (es) |
| MA (1) | MA26597A1 (es) |
| MY (1) | MY119090A (es) |
| NO (1) | NO329903B1 (es) |
| NZ (1) | NZ505492A (es) |
| PE (1) | PE20000269A1 (es) |
| PL (1) | PL202802B1 (es) |
| PT (1) | PT1049721E (es) |
| RU (1) | RU2211224C2 (es) |
| SA (1) | SA99191113B1 (es) |
| SI (1) | SI1049721T1 (es) |
| SK (1) | SK283411B6 (es) |
| TR (1) | TR200002078T2 (es) |
| TW (1) | TW548279B (es) |
| UA (1) | UA60352C2 (es) |
| UY (1) | UY25356A1 (es) |
| WO (1) | WO1999036443A1 (es) |
| ZA (1) | ZA99355B (es) |
Families Citing this family (17)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| FR2814463B1 (fr) * | 2000-09-22 | 2002-11-15 | Sanofi Synthelabo | Nouveaux polysaccharides a activite antithrombotique comprenant au moins une liaison covalente avec la biotine ou un derive de la biotine |
| FR2874924B1 (fr) | 2004-09-09 | 2006-12-01 | Sanofi Aventis Sa | Hexadecasaccharides biotinyles, leur preparation et leur utilisation therapeutique |
| TWI403334B (zh) | 2004-12-23 | 2013-08-01 | Merck Sharp & Dohme | 包含生物素殘基之抗血栓雙重抑制劑 |
| GB0507577D0 (en) | 2005-04-14 | 2005-05-18 | Novartis Ag | Organic compounds |
| IL188647A0 (en) * | 2008-01-08 | 2008-11-03 | Orina Gribova | Adaptable structured drug and supplements administration system (for oral and/or transdermal applications) |
| WO2009130704A1 (en) * | 2008-04-24 | 2009-10-29 | Technion Research And Development Foundation Ltd. | Beta-lactoglobulin-polysaccharide nanoparticles for hydrophobic bioactive compounds |
| KR101529061B1 (ko) | 2008-05-30 | 2015-06-16 | 모멘타 파머슈티컬스 인코포레이티드 | 당류 구조물, 그리고 이러한 구조물의 제조 및 사용 방법 |
| FR2935386B1 (fr) * | 2008-08-26 | 2010-09-10 | Sanofi Aventis | Nouveaux polysaccharides a activite antithrombotique comprenant une liaion covalente avec une chaine amine |
| WO2010117803A2 (en) * | 2009-03-30 | 2010-10-14 | University Of Georgia Research Foundation, Inc. | Heparan sulfate synthesis |
| US9060932B2 (en) | 2009-07-09 | 2015-06-23 | Oshadi Drug Administration Ltd. | Matrix carrier compositions, methods and uses |
| US8288515B2 (en) * | 2009-07-31 | 2012-10-16 | Reliable Biopharmaceutical Corporation | Process for preparing Fondaparinux sodium and intermediates useful in the synthesis thereof |
| FR2949114B1 (fr) | 2009-08-14 | 2011-08-26 | Sanofi Aventis | OCTASACCHARIDES N-ACYLES ACTIVATEURS DES RECEPTEURS DES FGFs, LEUR PREPARATION ET LEUR APPLICATION EN THERAPEUTIQUE |
| FR2949115B1 (fr) | 2009-08-14 | 2012-11-02 | Sanofi Aventis | OLIGOSACCHARIDES N-SULFATES ACTIVATEURS DES RECEPTEURS DES FGFs, LEUR PREPARATION ET LEUR APPLICATION EN THERAPEUTIQUE |
| US8420790B2 (en) | 2009-10-30 | 2013-04-16 | Reliable Biopharmaceutical Corporation | Efficient and scalable process for the manufacture of Fondaparinux sodium |
| JP2013537181A (ja) | 2010-09-10 | 2013-09-30 | サノフイ | 抗血栓活性及び改善された代謝安定性を有するビオチン化多糖類 |
| US9005664B2 (en) | 2010-10-17 | 2015-04-14 | Technion Research And Development Foundation Ltd. | Denatured lactoglobulin and polyphenol coassemblies |
| FR2970969B1 (fr) | 2011-01-27 | 2013-10-18 | Sanofi Aventis | Oligosaccharides 3-o-alkyles activateurs des recepteurs des fgfs, leur preparation et leur application en therapeutique |
Family Cites Families (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| NZ260933A (en) * | 1993-07-16 | 1996-07-26 | Hercules Inc | Cation-complexed polysaccharides; use in foods and pharmaceuticals |
| FR2749849B1 (fr) * | 1996-06-14 | 1998-09-04 | Sanofi Sa | Polysaccharides synthetiques, procede pour leur preparation et compositions pharmaceutiques les contenant |
| CZ427499A3 (cs) * | 1998-05-29 | 2000-05-17 | The Procter & Gamble Company | Jemné topické antimikrobiální přípravky |
-
1998
- 1998-01-19 FR FR9800515A patent/FR2773804B1/fr not_active Expired - Lifetime
-
1999
- 1999-01-13 JP JP2000540158A patent/JP4402835B2/ja not_active Expired - Fee Related
- 1999-01-13 AU AU19745/99A patent/AU741748B2/en not_active Ceased
- 1999-01-13 UA UA2000074011A patent/UA60352C2/uk unknown
- 1999-01-13 BR BRPI9907025A patent/BRPI9907025B8/pt not_active IP Right Cessation
- 1999-01-13 EE EEP200000429A patent/EE04157B1/xx unknown
- 1999-01-13 SI SI9930025T patent/SI1049721T1/xx unknown
- 1999-01-13 PT PT99900524T patent/PT1049721E/pt unknown
- 1999-01-13 US US09/600,506 patent/US6528497B1/en not_active Expired - Lifetime
- 1999-01-13 ES ES99900524T patent/ES2168000T3/es not_active Expired - Lifetime
- 1999-01-13 AT AT99900524T patent/ATE209219T1/de active
- 1999-01-13 DE DE69900718T patent/DE69900718T2/de not_active Expired - Lifetime
- 1999-01-13 PL PL341875A patent/PL202802B1/pl unknown
- 1999-01-13 EP EP99900524A patent/EP1049721B1/fr not_active Expired - Lifetime
- 1999-01-13 NZ NZ505492A patent/NZ505492A/en not_active IP Right Cessation
- 1999-01-13 WO PCT/FR1999/000044 patent/WO1999036443A1/fr active IP Right Grant
- 1999-01-13 IL IL13724199A patent/IL137241A0/xx not_active IP Right Cessation
- 1999-01-13 HU HU0102009A patent/HU228333B1/hu not_active IP Right Cessation
- 1999-01-13 RU RU2000119753/04A patent/RU2211224C2/ru not_active IP Right Cessation
- 1999-01-13 DK DK99900524T patent/DK1049721T3/da active
- 1999-01-13 TR TR2000/02078T patent/TR200002078T2/xx unknown
- 1999-01-13 SK SK1078-2000A patent/SK283411B6/sk not_active IP Right Cessation
- 1999-01-13 CN CNB998022438A patent/CN1165550C/zh not_active Expired - Fee Related
- 1999-01-13 CA CA002317465A patent/CA2317465C/en not_active Expired - Fee Related
- 1999-01-13 KR KR10-2000-7007824A patent/KR100513196B1/ko not_active IP Right Cessation
- 1999-01-13 CZ CZ20002635A patent/CZ297815B6/cs not_active IP Right Cessation
- 1999-01-14 GT GT199900003A patent/GT199900003A/es unknown
- 1999-01-15 MA MA25431A patent/MA26597A1/fr unknown
- 1999-01-16 EG EG5499A patent/EG23982A/xx active
- 1999-01-16 DZ DZ990010A patent/DZ2709A1/xx active
- 1999-01-18 AR ARP990100172A patent/AR013019A1/es active IP Right Grant
- 1999-01-18 MY MYPI99000203A patent/MY119090A/en unknown
- 1999-01-18 UY UY25356A patent/UY25356A1/es not_active Application Discontinuation
- 1999-01-18 TW TW088100716A patent/TW548279B/zh not_active IP Right Cessation
- 1999-01-19 ZA ZA9900355A patent/ZA99355B/xx unknown
- 1999-01-19 PE PE1999000044A patent/PE20000269A1/es not_active Application Discontinuation
- 1999-01-19 CO CO99002526A patent/CO4970795A1/es unknown
- 1999-02-27 SA SA99191113A patent/SA99191113B1/ar unknown
-
2000
- 2000-07-17 NO NO20003662A patent/NO329903B1/no not_active IP Right Cessation
- 2000-07-19 HR HR970630A patent/HRP20000480B1/xx not_active IP Right Cessation
-
2001
- 2001-02-12 HK HK01101003A patent/HK1030002A1/xx not_active IP Right Cessation
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| AR013019A1 (es) | Polisacarido de sintesis, su utilizacion y composiciones farmaceuticas que lo contienen | |
| POPE Jr et al. | Apparent neuroleptic malignant syndrome with clozapine and lithium | |
| SE8402549D0 (sv) | Substituerade moranolinderivat | |
| ES2438768T3 (es) | Composiciones y métodos para la profilaxis y el tratamiento de adicciones | |
| JPH05246851A (ja) | 抗炎症剤 | |
| AU610978B2 (en) | Onset-hastened/enhanced analgesia using s(+) ketoprofen | |
| NL8600555A (nl) | Farmaceutische formuleringen en werkwijze voor de behandeling van geheugenstoornissen. | |
| ES2160648T3 (es) | Derivados de piridina. | |
| FR2450832A1 (fr) | Nouveaux 3-(1-imidazolylalkyl) indoles, leur procede de production et composition pharmaceutique les contenant | |
| ES499870A0 (es) | Un procedimiento para la preparacion de derivados de indano | |
| EP2029566B1 (en) | Novel serotonin reuptake inhibitors as drugs having peripheral-system-restricted activity | |
| Kihara et al. | Antithrombotic activity of AT-1015, a potent 5-HT2A receptor antagonist, in rat arterial thrombosis model and its effect on bleeding time | |
| RU2000119753A (ru) | Синтетические полисахариды, способ их получения и содержащие их фармацевтические композиции | |
| FR2681324B1 (fr) | Nouveaux derives de la trimetazidine, leur procede de preparation et les compositions pharmaceutiques les contenant. | |
| US5137912A (en) | Chelerythrine inhibits platelet aggregation--a potential anti-aggregation drug | |
| US20070037756A1 (en) | Compositions and methods for the prevention and treatment of circulatory conditions | |
| Kwan et al. | Effects of hypoxia on the pharmacological responsiveness of isolated coronary artery rings from the sheep. | |
| ES2725707T3 (es) | Compuestos de tipo 1,2,4-triazolo[4,3-a]piridina y su uso como moduladores alostéricos positivos de receptores mglur2 | |
| ATE945T1 (de) | Antikoagulierungsmittel, verfahren zu dessen herstellung und es enthaltende pharmazeutische zusammensetzungen. | |
| JPH0114206B2 (es) | ||
| PE20240657A1 (es) | Derivados de 3-(1-oxoisoindolin-2-il)piperidina-2,6-diona y sus usos medicos | |
| ES471993A1 (es) | Procedimiento de preparacion de nuevos derivados de alcaloi-des pentaciclicos | |
| ES2039460T3 (es) | Un procedimiento para producir una solucion inyectable de glicosido de antraciclina. | |
| AR008245A1 (es) | Derivados de acido acetico, uso de los mismos en la fabricacion de un agente terapeutico y proceso para preparar dichos derivados | |
| BRPI0412928A (pt) | dibenzo[b,f]oxepina-10-carboxamidas e usos farmacêuticos das mesmas |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FG | Grant, registration |